Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose
Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose
Recalling Firm: Communications and Public Affairs Branch
Reason for Recall / Hazard
Labelling
Product Description & Identification
Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules.If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.
Affected Products
JAMP Venlafaxine XR 37.5 mg (lot PTC5140A) sold to pharmacies in bottles of 100 capsules for dispensing.
Additional Source Details
| Field | Value |
|---|---|
| N I D | 73862 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/certain-bottles-jamp-venlafaxine-xr-375-mg-capsules-recalled-due-mislabelling-could |
| Issue | Labelling |
| Title | Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose |
| Product | JAMP Venlafaxine XR 37.5 mg (lot PTC5140A) sold to pharmacies in bottles of 100 capsules for dispensing. |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2023-06-21 |
| Organization | Communications and Public Affairs Branch |
| What you should do | Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules.If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada. |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmCommunications and Public Affairs Branch
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Communications and Public Affairs Branch - Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose Check if your household is affected: https://therecallfile.com/recalls/certain-bottles-of-jamp-venlafaxine-xr-37-5-mg-capsules-recalled-due-t/CANADA-73862
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.